Clinical Trial Update: Exogenous Ketones for Acutely Decompensated HEart Failure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating exogenous ketones for acutely decompensated heart failure with low cardiac output; status and results are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Low Cardiac Output Syndrome

Snippet

Sponsor: Institute for Clinical and Experimental Medicine | Conditions: Acute Heart Failure, Low Cardiac Output Syndrome | Phase 3 | Status: UNKNOWN